Variants in the GH-IGF axis confer susceptibility to lung cancer.
about
Lung cancer susceptibility model based on age, family history and genetic variantsApoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancerGenetic susceptibility to lung cancer--light at the end of the tunnel?Effect of HLA-B-associated transcript 3 polymorphisms on lung cancer risk: a meta-analysisA novel, non-apoptotic role for Scythe/BAT3: a functional switch between the pro- and anti-proliferative roles of p21 during the cell cycleAPOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variantsInteractions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinomaIndividual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPDInfluence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controlsEffects of environment, genetics and data analysis pitfalls in an esophageal cancer genome-wide association study.Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).Analysis of protein sequence and interaction data for candidate disease gene prediction.Network evaluation from the consistency of the graph structure with the measured data.Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk.Lack of association of the TP53BP1 Glu353Asp polymorphism with risk of cancer: a systematic review and meta-analysis.Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populationsAnalysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an exampleShort-term, supra-physiological rhGH administration induces transient DNA damage in peripheral lymphocytes of healthy women.Exploring the potential relevance of human-specific genes to complex disease.The balance between heritable and environmental aetiology of human disease.Successful design and conduct of genome-wide association studies.Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.Collapsing SNP genotypes in case-control genome-wide association studies increases the type I error rate and power.Power analysis for case-control association studies of samples with known family histories.Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci.Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.Different non-synonymous polymorphisms modulate the interaction of the WRN protein to its protein partners and its enzymatic activities.The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population.A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic Variations.Association of calcium/calmodulin-dependent protein kinase kinase1 rs7214723 polymorphism with lung cancer risk in a Chinese population.Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a high-risk group.Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers.A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.Mutations in Fanconi anemia genes and the risk of esophageal cancer.
P2860
Q21091204-D5614381-2EA8-4E56-A16E-42BC124B0667Q23918557-E2497ACA-6264-4D82-8514-3A7560830972Q26852320-4BB61CF3-1065-4980-9279-B04878C2B06EQ28383836-A617AA10-5D40-479F-9827-5607ECC98ADEQ28385780-32C44227-46C6-47AB-846E-84AD5AB5C687Q28387051-D74FF22C-6828-4879-82D7-12EAE2F4F0AFQ28394515-7F1A010A-B69F-4D99-8E30-C83ADBB9CEAFQ28396031-2B383F8F-1C46-44DD-B59D-E87D791D1FE2Q28743099-04D2455C-A1C4-4101-86E8-10F8DEDE1150Q29417049-AFFCDB1B-C05B-4085-A9D2-76F454D5BC6FQ30834549-2AF0EDC8-AC51-4635-9F4C-48C9C7A5BFDBQ30847332-F740D4C3-8BB0-44BB-9F24-444F02328A07Q31064465-FE1BD841-3BFD-4347-8DED-03E55561B7EEQ33373148-AB7C64B3-0377-44C2-B24B-069972B309F2Q33772896-094AB1C8-0706-499D-B93A-7DA4D6F00F4FQ33817664-CE2E1196-D0CF-408A-A558-E8904F1FB94DQ33881163-9DCD017C-2532-4CEC-B280-A34F1BCD50E3Q34182483-D2965D29-CD4A-429D-8825-58E590165C91Q34224792-9B75F59A-17C2-4F33-9A7F-3FFBF5C518F5Q34796363-463C3A52-928B-4C3C-839D-1C1862478ED3Q35113054-46119497-631C-4025-9AD2-2289043A7721Q35462630-CCA41530-3AE8-4D8E-8D36-948FF40F5346Q35631708-C1E8C998-A00B-4F40-947A-B44F7D2D3C3EQ36283802-F58AB3C9-C532-43B3-8D9A-C5CE353A297AQ36475133-C455169B-CC4E-4265-801F-B85427A30A73Q36670492-1AF17148-3B36-409C-94B0-D77AB55CCF11Q36863254-4541C843-480A-49A5-829A-2E315FCD6A71Q37418923-F503A366-B991-4142-ABAC-0A487BDC49E5Q37461414-175DD469-7EF3-455C-95A3-464544C7D288Q37558019-4465CD1C-5DA5-4AA5-9EF8-3B2FA47F4A61Q37633874-74679CC5-5DA0-42C2-9FBD-04E387933E48Q37689865-54A3E67B-2149-465F-B009-A91A3C2945ABQ37699107-8E246726-6C75-4045-B522-AF0F03144F05Q38990801-836AC81E-5E2A-43D6-9A65-42E80E61677FQ39738163-2D483B5A-98DA-49AE-91E0-552D21356C27Q40110157-9EE39B24-525F-4DBB-9DB2-B11DBD733FE3Q44171693-8B841455-122A-45B6-912E-F882BF3B928BQ44767574-4C64A646-F99A-42B4-BBF7-076786ABFF06Q47716658-3F6C382D-70C5-4C50-B780-1480624218C2Q47857337-13933694-3375-41CE-BDED-59D063CA2FAF
P2860
Variants in the GH-IGF axis confer susceptibility to lung cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@ast
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@en
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@nl
type
label
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@ast
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@en
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@nl
prefLabel
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@ast
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@en
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Variants in the GH-IGF axis confer susceptibility to lung cancer.
@en
P2093
Athena Matakidou
GELCAPS Consortium
Gabrielle S Sellick
Helen Bridle
Matthew F Rudd
Richard D Williams
P2860
P304
P356
10.1101/GR.5120106
P577
2006-06-01T00:00:00Z